Navigation Links
BioMarin Announces FDA Approval for Kuvan
Date:12/13/2007

le for PKU patients. For more information about the BioMarin Patient and Physician Support Program, please call 877-MY-KUVAN (877.695.8826). For more information about Kuvan, please visit http://www.Kuvan.com.

Conference Call

BioMarin will host a conference call and webcast to discuss the Kuvan approval today, Thursday, December 13, at 5:00 p.m. ET. This event can be accessed on the investor section of the BioMarin website at http://www.BMRN.com.

Date: December 13, 2007

Time: 5:00 p.m. ET

U.S. / Canada Dial-in Number: 800.510.9661

International Dial-in Number: 617.614.3452

Participant Code: 95299072

Replay Dial-in Number: 888.286.8010

Replay International Dial-in Number: 617.801.6888

Replay Code: 61294597

About Kuvan

Kuvan(TM) (sapropterin dihydrochloride) Tablets is indicated to reduce blood phenylalanine (Phe) levels in patients with hyperphenylalaninemia (HPA) due to tetrahydrobiopterin- (BH4-) responsive phenylketonuria (PKU). Kuvan is to be used in conjunction with a Phe-restricted diet.

The active ingredient in Kuvan, sapropterin dihydrochloride, is the synthetic form of 6R-BH4 (tetrahydrobiopterin), a naturally occurring enzyme cofactor that works in conjunction with phenylalanine hydroxylase (PAH) to metabolize Phe. BioMarin and Merck Serono estimate that Kuvan could be a potential treatment option for approximately 30 percent to 50 percent of the estimated 50,000 identified PKU patients in the developed world.

Kuvan has received orphan drug designation from both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMEA). Kuvan has received seven years of market exclusivity in the United States. In November 2007, Merck Serono submitted a Marketing Authorization Application (MAA) to the EMEA for sapropterin dihydrochloride as an oral treatm
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... , May 1, 2015  An effective advisory ... provide non-binding but informed guidance to pharmaceutical organizations ... on investment, it is important for leaders to ... resources. Research and consulting leader ... assist pharmaceutical and medical device executives in identifying ...
(Date:5/1/2015)... /PRNewswire/ --Research and Markets ( http://www.researchandmarkets.com/research/vzcw2v/americas_clinical ) ... Analyzer Market by Product, by End-Users - Forecast to 2019" ... Chemistry Analyzers market is estimated to grow at a CAGR ... U.S., Canada , Mexico ... (RoA) are covered in this report. The Americas ...
(Date:5/1/2015)... , May 1, 2015 Following yesterday,s release of ... D, here are five things you need to know: ... market-based structure is unique among government programs. ... D is different than other parts of Medicare and other ... that submit bids to offer prescription drug benefits to enrollees. ...
Breaking Medicine Technology:New Study Presents Insights to Advisory Board Effectiveness in the Pharmaceutical Sector 2Americas Clinical Chemistry Analyzer (Semi-Automated Clinical Chemistry and Fully-Automated Clinical Chemistry) Market - Forecast to 2019 25 Things to Know About the CMS Part D Data Release 25 Things to Know About the CMS Part D Data Release 3
(Date:5/3/2015)... Clarkston, Metamora, Michigan (PRWEB) May 03, 2015 ... ‘Like’ mark on their Facebook page. , ... patients on the many services the Practice has, it’s ... current events. , Women’s Excellence has a very strong ... +, Pinterest, Instagram and You Tube. , Women’s ...
(Date:5/3/2015)... Bubbly Walrus ” was featured on NewsWatch as part of ... and coolest applications on the market for iOS, Android, and ... conducted the app review and shared with viewers how this ... to play on smartphones are the ones that get users ... a video game that just absorbs attention, why not exercise ...
(Date:5/3/2015)... LOUIS, Missouri (PRWEB) May 03, 2015 ... international business that will directly impact your career? ... is designed for dynamic leaders in multinational companies ... multinational company. In a changing global landscape, differences ... negotiations and relationships. The EMIB program develops the ...
(Date:5/3/2015)... Hanover, MA (PRWEB) May 03, 2015 It is ... 3rd Annual Brain Aneurysm Walk in Memory of Lissa Anne Been ... of Lissa organized this great family-friendly event to honor her loving ... since its inception. , Just having turned 37, Lissa suffered ... Lissa passed away on August 24, 2012. This event is designed ...
(Date:5/2/2015)... Ticket Down has secured additional inventories of authentic ... event today, Saturday, May 2nd at the MGM Grand Garden ... able to secure tickets for both the actual fight and ... have wanted for more than five years was finally been ... step inside the ring to fight Manny “Pac-Man” Pacquiao in ...
Breaking Medicine News(10 mins):Health News:An Application to Have Fun with Mathematics Was Featured on NewsWatch Television 2Health News:The Saint Louis University's Master of International Business Is Now Enrolling For Fall 2015 2Health News:Renowned Brain Aneurysm Foundation to Benefit from Arnold, Missouri’s 3rd Annual Brain Aneurysm Walk in Memory of Lissa Anne Been 2Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 2Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 3
... Supervised exercise was shown to be more effective than ... with peripheral artery disease. The findings from a national ... Association Scientific Sessions meeting. Rhode Island Hospital is one ... Peripheral artery disease (PAD) is a condition in ...
... TUESDAY, Nov. 15 (HealthDay News) -- Entering adulthood in a place ... 21, seems to put women, but not men, at a long-term ... "We want to make sure people know all of the consequences ... an assistant professor in the department of psychiatry at Washington University ...
... News) -- Scientists who identified a gene linked to ... targeted treatments for anxiety disorders. The researchers assessed ... called 7q11.23 duplication syndrome (Dup7q11.23) and Williams-Beuren syndrome (WBS). ... anxiety and specific phobias. It,s caused by extra copies ...
... About half of male breast cancer patients who take the ... effects such as weight gain and sexual dysfunction, which prompts ... to researchers at The University of Texas MD Anderson Cancer ... date of how the estrogen-blocking drug is tolerated in men ...
... have found a way to load more than 2 million ... The breakthrough could speed development of cancer treatments that would ... the inside. The research appears online this week in ... "The breast cancer cells that we studied were so laden ...
... A potential breakthrough in treating late-stage ovarian cancer has ... a peptide that shrinks advanced tumours and improves survival ... "We,re extremely excited about this," said Jim Petrik, a ... who conducted the research with PhD student Nicole Campbell. ...
Cached Medicine News:Health News:Exercise may be better than stents for PAD patients 2Health News:Higher Legal Drinking Age May Mean Safer Lives for Women 2Health News:Higher Legal Drinking Age May Mean Safer Lives for Women 3Health News:Gene Linked to Separation Anxiety 2Health News:Tamoxifen causes significant side effects in male breast cancer patients 2Health News:Tamoxifen causes significant side effects in male breast cancer patients 3Health News:Rice chemists cram 2 million nanorods into single cancer cell 2Health News:Discovery may help fight late-stage ovarian cancer 2
... Spirit is the premium APAP device in ... The AutoSet algorithm responds to the patients ... flow generator stores and reports comprehensive clinical ... AutoSet devices combine integrated humidification and a ...
Paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
... System provides the capability to ... middle of surgery while retaining ... incision. The system is also ... for large patients while remaining ...
These retractors, made of rugged Noryl® resin, are pre-sterilized and packaged singly in double peel-pouches for easy delivery to the sterile surgical field....
Medicine Products: